Janpix
Janpix is discovering and developing inhibitors of Signal Transducer and Activator of Transcription (“STAT”) proteins. Most members of this family of transcription factors have been known for some time and their relevance in certain cancers, in particular for STAT3 & STAT5, validated. Inhibiting the function of STAT proteins though has been very challenging thus far and Janpix developed new chemistry to address this complex problem.
Domain
janpixbio.com
Country
United StatesIndustry
App DiscoveryEmployees
11-50
Last Funding
$10.0M
Founded
2012
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Janpix use?+
We have not yet detected technologies for Janpix.
What industry is Janpix in?+
Janpix operates in the App Discovery industry.
Where is Janpix based?+
Janpix is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026